Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 16231 | 17.7 |
09:34 ET | 3340 | 17.635 |
09:36 ET | 2938 | 17.57 |
09:38 ET | 2887 | 17.57 |
09:39 ET | 4090 | 17.69 |
09:41 ET | 2810 | 17.635 |
09:43 ET | 10403 | 17.655 |
09:45 ET | 11075 | 17.825 |
09:48 ET | 10315 | 17.87 |
09:50 ET | 3373 | 17.8759 |
09:52 ET | 10117 | 17.895 |
09:54 ET | 11056 | 17.9154 |
09:56 ET | 15367 | 17.86 |
09:57 ET | 19410 | 17.94 |
09:59 ET | 8783 | 17.89 |
10:01 ET | 4406 | 17.975 |
10:03 ET | 12071 | 17.98 |
10:06 ET | 31132 | 17.995 |
10:08 ET | 11614 | 17.99 |
10:10 ET | 7306 | 17.92 |
10:12 ET | 8949 | 17.98 |
10:14 ET | 2600 | 17.96 |
10:15 ET | 3220 | 17.955 |
10:17 ET | 8238 | 17.94 |
10:19 ET | 2900 | 17.96 |
10:21 ET | 1268 | 17.98 |
10:24 ET | 8031 | 18.0391 |
10:26 ET | 7144 | 18.05 |
10:28 ET | 5143 | 18.08 |
10:30 ET | 1679 | 18.06 |
10:32 ET | 13080 | 17.95 |
10:33 ET | 4747 | 17.92 |
10:35 ET | 2450 | 17.92 |
10:37 ET | 7011 | 17.91 |
10:39 ET | 2898 | 17.89 |
10:42 ET | 4808 | 17.88 |
10:44 ET | 6004 | 17.84 |
10:46 ET | 2380 | 17.88 |
10:48 ET | 4846 | 17.87 |
10:50 ET | 6592 | 17.9 |
10:51 ET | 779 | 17.89 |
10:53 ET | 11829 | 17.86 |
10:55 ET | 20573 | 17.84 |
10:57 ET | 2408 | 17.8 |
11:00 ET | 2728 | 17.8 |
11:02 ET | 2250 | 17.83 |
11:04 ET | 809 | 17.83 |
11:06 ET | 5061 | 17.84 |
11:08 ET | 2139 | 17.82 |
11:09 ET | 2374 | 17.83 |
11:11 ET | 2300 | 17.85 |
11:13 ET | 11994 | 17.84 |
11:15 ET | 1027 | 17.83 |
11:18 ET | 2149 | 17.8 |
11:20 ET | 2775 | 17.82 |
11:22 ET | 1100 | 17.82 |
11:24 ET | 3033 | 17.81 |
11:26 ET | 400 | 17.8 |
11:27 ET | 14965 | 17.87 |
11:29 ET | 3881 | 17.88 |
11:31 ET | 6335 | 17.86 |
11:33 ET | 3001 | 17.85 |
11:36 ET | 2855 | 17.86 |
11:38 ET | 4609 | 17.87 |
11:40 ET | 1434 | 17.87 |
11:42 ET | 4891 | 17.89 |
11:44 ET | 1230 | 17.89 |
11:45 ET | 600 | 17.88 |
11:47 ET | 4486 | 17.91 |
11:49 ET | 2011 | 17.86 |
11:51 ET | 1000 | 17.86 |
11:54 ET | 1000 | 17.86 |
11:56 ET | 600 | 17.86 |
11:58 ET | 1274 | 17.87 |
12:00 ET | 17112 | 17.86 |
12:02 ET | 2788 | 17.84 |
12:03 ET | 2305 | 17.83 |
12:05 ET | 6513 | 17.8 |
12:07 ET | 2475 | 17.79 |
12:09 ET | 20606 | 17.75 |
12:12 ET | 2113 | 17.75 |
12:14 ET | 7798 | 17.75 |
12:16 ET | 2371 | 17.77 |
12:18 ET | 3684 | 17.79 |
12:20 ET | 100 | 17.79 |
12:23 ET | 3103 | 17.78 |
12:25 ET | 1700 | 17.76 |
12:27 ET | 600 | 17.75 |
12:30 ET | 1100 | 17.74 |
12:32 ET | 2000 | 17.72 |
12:34 ET | 1000 | 17.71 |
12:36 ET | 3094 | 17.71 |
12:38 ET | 1759 | 17.71 |
12:39 ET | 2042 | 17.69 |
12:41 ET | 2543 | 17.69 |
12:43 ET | 3150 | 17.74 |
12:45 ET | 2928 | 17.73 |
12:48 ET | 4372 | 17.72 |
12:50 ET | 1281 | 17.71 |
12:52 ET | 713 | 17.71 |
12:54 ET | 20369 | 17.7 |
12:56 ET | 9522 | 17.71 |
12:57 ET | 3119 | 17.75 |
12:59 ET | 2224 | 17.74 |
01:01 ET | 9936 | 17.73 |
01:03 ET | 5305 | 17.7 |
01:06 ET | 1862 | 17.68 |
01:08 ET | 800 | 17.69 |
01:10 ET | 800 | 17.67 |
01:12 ET | 1199 | 17.695 |
01:14 ET | 700 | 17.69 |
01:15 ET | 500 | 17.69 |
01:17 ET | 3104 | 17.74 |
01:19 ET | 1764 | 17.77 |
01:21 ET | 840 | 17.79 |
01:24 ET | 1300 | 17.79 |
01:26 ET | 12805 | 17.78 |
01:28 ET | 846 | 17.78 |
01:30 ET | 690 | 17.78 |
01:32 ET | 1100 | 17.78 |
01:33 ET | 1949 | 17.83 |
01:35 ET | 300 | 17.84 |
01:37 ET | 2789 | 17.86 |
01:39 ET | 1669 | 17.83 |
01:42 ET | 12810 | 17.87 |
01:44 ET | 743 | 17.86 |
01:46 ET | 1926 | 17.85 |
01:48 ET | 2883 | 17.86 |
01:50 ET | 400 | 17.84 |
01:51 ET | 2400 | 17.83 |
01:53 ET | 200 | 17.84 |
01:55 ET | 1866 | 17.85 |
01:57 ET | 2902 | 17.82 |
02:00 ET | 2273 | 17.79 |
02:02 ET | 800 | 17.81 |
02:04 ET | 740 | 17.815 |
02:06 ET | 1367 | 17.82 |
02:08 ET | 803 | 17.84 |
02:09 ET | 1779 | 17.86 |
02:11 ET | 5056 | 17.87 |
02:13 ET | 14214 | 17.89 |
02:15 ET | 4233 | 17.93 |
02:18 ET | 1021 | 17.96 |
02:20 ET | 3311 | 17.96 |
02:22 ET | 1500 | 17.94 |
02:24 ET | 2346 | 17.89 |
02:26 ET | 13851 | 17.825 |
02:27 ET | 14411 | 17.89 |
02:29 ET | 42898 | 17.88 |
02:31 ET | 1571 | 17.9 |
02:33 ET | 1282 | 17.9 |
02:36 ET | 7475 | 17.88 |
02:38 ET | 9004 | 17.87 |
02:40 ET | 1413 | 17.86 |
02:42 ET | 12338 | 17.88 |
02:44 ET | 22445 | 17.855 |
02:45 ET | 4995 | 17.84 |
02:47 ET | 4090 | 17.8 |
02:49 ET | 2422 | 17.81 |
02:51 ET | 5944 | 17.84 |
02:54 ET | 2159 | 17.8065 |
02:56 ET | 3033 | 17.805 |
02:58 ET | 3411 | 17.81 |
03:00 ET | 1193 | 17.795 |
03:02 ET | 1775 | 17.76 |
03:03 ET | 3800 | 17.73 |
03:05 ET | 809 | 17.73 |
03:07 ET | 2894 | 17.71 |
03:09 ET | 9940 | 17.77 |
03:12 ET | 600 | 17.77 |
03:14 ET | 3234 | 17.81 |
03:16 ET | 1100 | 17.81 |
03:18 ET | 2766 | 17.8 |
03:20 ET | 820 | 17.8 |
03:21 ET | 200 | 17.81 |
03:23 ET | 7079 | 17.84 |
03:25 ET | 1668 | 17.825 |
03:27 ET | 10443 | 17.785 |
03:30 ET | 4599 | 17.735 |
03:32 ET | 6688 | 17.76 |
03:34 ET | 2336 | 17.795 |
03:36 ET | 3807 | 17.815 |
03:38 ET | 8399 | 17.82 |
03:39 ET | 1403 | 17.8001 |
03:41 ET | 500 | 17.8 |
03:43 ET | 3850 | 17.795 |
03:45 ET | 7709 | 17.81 |
03:48 ET | 4172 | 17.825 |
03:50 ET | 14552 | 17.825 |
03:52 ET | 10426 | 17.8 |
03:54 ET | 9403 | 17.805 |
03:56 ET | 22167 | 17.795 |
03:57 ET | 15518 | 17.795 |
03:59 ET | 60967 | 17.77 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.9B | -1,380.7x | --- |
Azenta Inc | 2.9B | -19.6x | --- |
PTC Therapeutics Inc | 2.6B | -4.3x | --- |
Guardant Health Inc | 3.8B | -7.9x | --- |
Amicus Therapeutics Inc | 3.1B | -21.1x | --- |
Novavax Inc | 1.8B | -4.1x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9B |
---|---|
Revenue (TTM) | $813.8M |
Shares Outstanding | 165.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-0.01 |
Book Value | $2.62 |
P/E Ratio | -1,380.7x |
Price/Sales (TTM) | 3.6 |
Price/Cash Flow (TTM) | 328.3x |
Operating Margin | -0.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.